The increasing demand for eligible study patient populations in order to prepare markets for new medicines as well as the need for more cost-efficient clinical development programs are the key reasons why the pharma industry is conducting clinical trials in the CEE and CIS region. However, there are a number of challenges that all industry stakeholders need to overcome in order to conduct clinically and commercially successful trials.
This unique event offers participants the opportunity to meet and discuss these current issues as well as network with fellow professionals. With over 15 high profile speakers and panellists from across Europe and Asia this conference is one not to be missed! To join the debate, click here.